SBTX
Silverback Therapeutics Inc
Price:  
5.87 
USD
Volume:  
116,700.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SBTX WACC - Weighted Average Cost of Capital

The WACC of Silverback Therapeutics Inc (SBTX) is 7.5%.

The Cost of Equity of Silverback Therapeutics Inc (SBTX) is 11.30%.
The Cost of Debt of Silverback Therapeutics Inc (SBTX) is 5.00%.

Range Selected
Cost of equity 9.00% - 13.60% 11.30%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.3% - 8.6% 7.5%
WACC

SBTX WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 0.96 1.4
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.00% 13.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.3% 8.6%
Selected WACC 7.5%